MSI Methylation Sciences Competitors and Similar CompaniesClear all
MSI Methylation Sciences's competitors and similar companies include Alector, HMNC, Stalicla and Supernus Pharmaceuticals.
 MSI Methylation Sciences MSI Methylation Sciences is a biotechnology company focused on the central nervous system (CNS) area. |  Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. |  HMNC HMNC is a biotechnology company that establishes personalized medicine in psychiatry and develops medications for depression and anxiety disorders. |  Stalicla Stalicla is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders. |  Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. | |
Founding Date | Founding Date 2007 | Founding Date 2013 | Founding Date 2010 | Founding Date 2017 | Founding Date 2005 |
Type | Type Private | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Surrey, CA HQ | Locations San Francisco, US HQ | Locations München, DE HQ | Locations Genève, CH HQ | Locations Rockville, US HQ |
Employees | Employees 5 | Employees 2382% decrease | Employees 3 | Employees 264% increase | Employees 6527% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 495.3 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.9 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $21m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $719m (FY, 2025) |
Net income | Net income N/A | Net income ($142.9m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($38.6m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 30m (over 9 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 8m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 194.5m | Total funding raised N/A | Total funding raised $ 18.2m | Total funding raised $ 69.5m |
For sources of this data, please see the company profile
View Company Profiles
Alector
HQ
San Francisco, US
Employees
238↓ 2% decrease
Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.
View companyHMNC
HQ
München, DE
Employees
3
HMNC is a biotechnology company that establishes personalized medicine in psychiatry and develops medications for depression and anxiety disorders.
View companyStalicla
HQ
Genève, CH
Employees
26↑ 4% increase
Stalicla is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders.
View companySupernus Pharmaceuticals
HQ
Rockville, US
Employees
652↑ 7% increase
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View company